TIRZEPATIDE Tirzepatide Research Blend · GLP-1/GIP Agonist · 10mg | 20mg | 30mg
Tirzepatide (GLP-2) is a synthetic dual incretin peptide targeting both GLP-1 and GIP receptor pathways. Work with it centers on glucose-dependent insulinotropic signaling and metabolic regulation.
Purity >99%Form Lyophilized PowderNo Endotoxins
Notify me when back in stock
Peer-Reviewed Literature
Related Studies
Peer-Reviewed Literature
Related Studies
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine
72-week landmark trial of 2,539 patients showed tirzepatide achieved body weight reductions of 15.0–20.9% versus 3.1% placebo — establishing dual GIP/GLP-1 agonism superiority.
Tirzepatide Versus Semaglutide Once Weekly in Patients With Type 2 Diabetes (SURPASS-2)
New England Journal of Medicine
Head-to-head trial of 1,879 patients showed tirzepatide achieved superior HbA1c reduction and greater weight loss (5.5–7.3 kg) than semaglutide 1 mg.
Tirzepatide After Intensive Lifestyle Intervention in Adults With Overweight or Obesity (SURMOUNT-3)
Nature Medicine
72-week trial showed tirzepatide achieved additional 18.4% weight loss beyond intensive lifestyle intervention, with 95% reaching ≥5% total weight loss.
Efficacy and Safety of Tirzepatide in Patients With Type 2 Diabetes (SURPASS-1)
The Lancet
40-week monotherapy trial showed tirzepatide produced superior HbA1c reduction of 1.9–2.5% and weight loss of 7.0–9.5 kg, with 92% achieving HbA1c <7%.
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)
New England Journal of Medicine
Head-to-head comparison showed tirzepatide 15 mg reduced HbA1c by 2.46% vs semaglutide 1 mg 1.86%, with body weight reductions of 12.4 kg vs 6.2 kg at 40 weeks in 1,879 T2D patients.
Tirzepatide Once Weekly for the Treatment of Obesity in People Without Diabetes (SURMOUNT-1)
New England Journal of Medicine
In 2,539 adults with BMI ≥30, tirzepatide 15 mg produced 22.5% mean body weight loss at 72 weeks — the largest weight reduction ever achieved with a pharmaceutical agent at the time.
TIRZEPATIDE FAQ
Where can I buy tirzepatide online?
Tirzepatide is for sale from Blank Peptides in 10mg, 20mg and 30mg vials made in our cGMP labs in the USA. A lot-matched certificate of analysis is published before you order. This is research grade material supplied to researchers, with no prescription step and a processing time within 1 business day.
What is tirzepatide?
Tirzepatide is a synthetic dual agonist peptide with activity at both the GIP and GLP-1 receptors. Its sequence is built on a GIP backbone with modifications that extend half-life. Pharmacology research has focused on how simultaneous engagement of two incretin receptors differs from single receptor agonism. We supply it as a laboratory reference compound.
What purity is your tirzepatide?
Greater than 99%. Each lot is run by HPLC and mass spectrometry in our own lab and then independently at Freedom Diagnostics or Horizon Analytical, with bacterial endotoxin testing performed on the release batch. The certificate is specific to the lot number printed on your vial, so you can verify the exact material you receive.
How do I reconstitute tirzepatide 10mg?
Add 1mL of bacteriostatic water for 10mg/mL. The 20mg vial takes 2mL and the 30mg takes 3mL, which is our ceiling for any single vial. Introduce the solvent slowly against the glass rather than onto the cake, then swirl. Give it a minute; the solution should be clear and free of particulates.
Which tirzepatide vial size should I order?
Same peptide, same purity, different mass. The 10mg suits short pilot work. The 20mg and 30mg lower the cost per milligram and make sense for extended laboratory runs or designs with several arms. Because our reconstitution ratio scales, every size ends up at 10mg/mL, which keeps concentration calculations identical across sizes.
How should tirzepatide be stored?
Sealed lyophilized vials at -20C, protected from light and moisture. Freeze-dried peptide handles ambient shipping temperatures without degradation. After reconstitution, refrigerate at 2 to 8C and use the solution within a few weeks. Aliquot rather than repeatedly freezing and thawing if the work runs over a longer window.
Tirzepatide vs retatrutide: what is the difference?
Receptor coverage. Tirzepatide is a dual GIP and GLP-1 receptor agonist. Retatrutide is a triple agonist that adds glucagon receptor activity, and semaglutide sits at the other end as a GLP-1 only agonist. Comparative pharmacology studies use the three together to isolate what each additional receptor contributes.
How quickly does tirzepatide ship?
Processing time is within 1 business day, then standard domestic transit from inside the USA. Outer packaging is unmarked. Blank Peptides emails tracking as soon as the label prints, and multi-vial packs travel in a single box rather than split shipments.
Is this tirzepatide for human use?
No. It is an unapproved research chemical sold for laboratory use only, not a drug, supplement or veterinary product, and it carries no FDA approval in this form. Do not treat it as equivalent to any prescription product. Ordering confirms you are a qualified researcher and the material stays in a research setting.